EOG
28
2
LUV
45
3
CVX
25
14
NKE
36
2
GOOG
77
14
PLD
35
5
HPQ
55
3
SLG
37
6
LB
16
9
WFC
58
8
MMC
46
5
ECL
54
5
CAG
34
3
BXP
39
5
KR
50
5
NDAQ
46
2
AKAM
50
2
XRX
48
2
HBAN
47
7
AMAT
33
3
EOG
28
2
LUV
45
3
CVX
25
14
NKE
36
2
GOOG
77
14
PLD
35
5
HPQ
55
3
SLG
37
6
LB
16
9
WFC
58
8
MMC
46
5
ECL
54
5
CAG
34
3
BXP
39
5
KR
50
5
NDAQ
46
2
AKAM
50
2
XRX
48
2
HBAN
47
7
AMAT
33
3
Financhill
Back

Genmab AS Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28

GNMSF
Genmab AS

Last Price:
$213.00
Seasonality Move:
-1.52%

7 Day Trial

ALL ACCESS PASS

$ 7

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here
  • The current trend is relatively stagnant and GNMSF is experiencing buying pressure, which is a positive indicator for future bullish movement.

Genmab AS Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 205.2 Buy
20-day SMA: 210.21 Sell
50-day SMA: 217.96 Sell
200-day SMA: 259.62 Sell
8-day EMA: 207.07 Buy
20-day EMA: 210.2 Sell
50-day EMA: 219.36 Sell
200-day EMA: 255.59 Sell

Genmab AS Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.72 Sell
Relative Strength Index (14 RSI): 48.47 Sell
Chaikin Money Flow: 1558 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (202.15 - 217.01) Sell
Bollinger Bands (100): (214.16 - 263.6) Sell

Genmab AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Genmab AS Stock

Is Genmab AS Stock a Buy?

  • Genmab AS share price is 209.50 while GNMSF 8-day simple moving average is 205.20, which is a Buy signal.
  • The stock price of GNMSF is 209.50 while Genmab AS 20-day SMA is 210.21, which makes it a Sell.
  • Genmab AS 50-day simple moving average is 217.96 while GNMSF share price is 209.50, making it a Sell technically.
  • GNMSF stock price is 209.50 and Genmab AS 200-day simple moving average is 259.62, creating a Sell signal.

GNMSF Technical Analysis vs Fundamental Analysis

Sell
28
Genmab AS (GNMSF) is a Sell

Is Genmab AS a Buy or a Sell?

  • Genmab AS stock is rated a Sell
    The current Genmab AS [GNMSF] share price is $209.50. The Score for GNMSF is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.

Genmab AS Stock Info

Market Cap:
13.3B
Price in USD:
209.50
Share Volume:
1.6K

Genmab AS 52-Week Range

52-Week High:
334.33
52-Week Low:
192.20
Sell
28
Genmab AS (GNMSF) is a Sell

Genmab AS Share Price Forecast

  • What is the Genmab AS stock price today?
    The Genmab AS stock price is 209.50 USD today.
  • Will GNMSF stock go up or go down?
    Genmab AS> share price is forecast to RISE/FALL based on technical indicators
  • Is Genmab AS overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Genmab AS is overvalued.

Is Genmab AS Stock a Buy?

  • Genmab AS share price is 209.50 while GNMSF 8-day exponential moving average is 207.07, which is a Buy signal.
  • The stock price of GNMSF is 209.50 while Genmab AS 20-day EMA is 210.20, which makes it a Sell.
  • Genmab AS 50-day exponential moving average is 219.36 while GNMSF share price is 209.50, making it a Sell technically.
  • GNMSF stock price is 209.50 and Genmab AS 200-day simple moving average is 255.59, creating a Sell signal.

Technical Analysis of Genmab AS

Should I short Genmab AS stock?

  • GNMSF Moving Average Covergence Divergence (MACD) indicator is -3.72, suggesting Genmab AS is a Sell
  • Genmab AS Relative Strength Index (RSI) is 48.47, which suggest Genmab AS is oversold
  • The Bollinger Bands (25) for Genmab AS is (202.15 - 217.01), which suggest Genmab AS is a Sell
  • The Bollinger Bands (100) for Genmab AS is (214.16 - 263.6), which suggest Genmab AS is a Sell

* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.